Loading...
Nous aimerions que vous fassiez partie de notre communauté. Rejoignez notre Discord pour échanger avec nous et les autres membres !
- Ticker
- MSE.PA
- Price
- 61.93
- Stock movement up
- +0.27 (0.44%)
- Company name
- Amundi EURO STOXX 50 II UCITS ETF Acc
- Exchange
- (PA ,
- Currency
- EUR )
- Capitalisation boursière
- -
- Valeur d'entreprise
- -
- Cours/chiffre d'affaires
- -
- Cours/valeur comptable
- -
- Rendement du div
- -
- Croissance du div
- -
- Années de croissance
- -
- Versement FCF
- -
- Trailing P/E
- -
- P/E prévisionnel
- -
- PEG
- -
- Croissance EPS
- -
- Rendement sur 1 an
- 19.12%
- Rendement sur 3 ans
- -
- Rendement sur 5 ans
- -
- Rendement sur 10 ans
- -
Dernière modification : 2025-11-20
DIVIDENDES
MSE.PA ne verse pas de dividendes
VALORISATION
Ratios de valorisation
Loading...
Données de ratios de valorisation
| Trailing P/E | - |
| Cours/OCF | - |
| Cours/FCF | - |
| Cours/EBITDA | - |
| EV/EBITDA | - |
Valorisation (Chiffre d'affaires/valeur comptable)
Loading...
Données de valorisation (Chiffre d'affaires/valeur comptable)
| Cours/chiffre d'affaires | - |
| Cours/valeur comptable | - |
| EV/chiffre d'affaires | - |
DONNEES FINANCIERES
INFORMATIONS SUR LES ACTIONS
Graphique boursier
Loading...
Données du prix des actions
| Ouverture | 62.43 |
| Max journalier | 62.60 |
| Min journalier | 61.93 |
| Volume journalier | 77K |
| Niveau record | 64.39 |
| Estimation des analystes sur 1 an | - |
| Beta | 1.07 |
| EPS (TTM) | - |
| Dividende par action | 0.00 |
| Date ex-div | 9 Dec 2020 |
| Prochaine date de bénéfices | - |
Potentiel de baisse
Loading...
Données du potentiel de baisse
| MSE.PA | S&P500 | |
| Baisse de prix actuelle par rapport au niveau record | -3.82% | -5.07% |
| Baisse de prix actuelle la plus importante | -16.40% | -19.00% |
| Date de la baisse la plus importante | 9 Apr 2025 | 8 Apr 2025 |
| Baisse moyenne par rapport au record | -2.41% | -2.73% |
| Délai moyen pour nouveau record | 8 days | 6 days |
| Délai max pour nouveau record | 68 days | 89 days |
INFORMATIONS SUR LA SOCIETE
Capitalisation boursière
-
Catégorie de capitalisation boursière
Description
The Lyxor EURO STOXX 50 (DR) UCITS ETF is a UCITS compliant exchange traded fund that aims to track the benchmark index EURO STOXX 50 Net Return EUR, offsetting the impact of daily variations of the index local currency vs. the USD. The USD-hedged share class offers the simplicity of a daily currency hedge mechanism that is embedded in the investment product, representing an efficient solution to manage the foreign-exchange risk.The EURO STOXX 50 Net Return EUR is Europe's leading Blue-chip index for the Eurozone providing a Blue-chip representation of supersector leaders in the Eurozone from 50 stocks and over 12 Eurozone countries. It captures approximately 60% of the free float market capitalisation of the EURO STOXX Total Market Index (TMI), which in turn covers approximately 95% of the free float market capitalisation of the represented countries. More information on www.stoxx.com.
Employés
Communication financière
-
Dossiers SEC
CEO
Pays
France
Ville
Type d'action
-
Statut CCC
-
Fréquences des dividendes
-
EVENEMENTS ET PRESENTATIONS
EvénementsPrésentations
Loading...
COMPRENDRE LE METIER
Loading...
ACTUALITES DE LA SOCIETE
Toute l'actualitéCommuniqués de presse
Thinking about what to do with your GL Events shares? Whether you are sizing up an entry point or reassessing your position after a strong rally, now is a great time to take stock of what is really ha...
9 septembre 2025
If you are weighing your next move with Banca IFIS, you are not alone. After all, the stock has served up a mix of intrigue and promise this year, catching plenty of attention across the financial lan...
9 septembre 2025
The cider brand has added a high-contrast NaviLens QR code to its cans.
9 septembre 2025
BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty
9 septembre 2025
Temenos also the winner for Bank Deposit Transformation with Credem and listed in the 2025 IDC FinTech Rankings Top 25GRAND-LANCY, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), ...
9 septembre 2025
The Management Board of Artea Bankas has approved changes to the management and organizational structure. The Management Board has received a notice from board member Mindaugas Rudys regarding his res...
9 septembre 2025
Novartis agreed to buy Tourmaline Bio in a roughly $1.4 billion-dollar deal that boosts its cardiovascular drug pipeline with access to the targeted therapy drug pacibekitug. The Swiss pharmaceuti...
9 septembre 2025
Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmali...
9 septembre 2025